- Tytuł:
- Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancer
- Autorzy:
- Źródło:
- In Cancer Genetics August 2022 266-267:1-6
Czasopismo naukowe